Concepedia

M. Plana

MP

Statistics

Publications

2

Citations

30

H-Index

2

Active since

2022

Affiliations

Institut Català d'Oncologia(Current)

M. Plana is an author at Institut Català d'Oncologia specializing in thyroid cancer, durvalumab therapy, and refractory thyroid carcinoma.

Publications per year

2022–2025

2

Publications

2

Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial

J. Bourhis, A. Auperin, Christian Borel et al. · The Lancet · 2025 · 18 citations

, , +9

1645O Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial

J. Capdevila Castillón, M. Plana, B. Castelo et al. · Annals of Oncology · 2022 · 12 citations

, , +6

1–2 of 2